You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK (GenomeWeb) – Roche has received the CE-IVD mark for a test to detect and distinguish Chlamydia trachomatis and Neisseria gonorrhoeae on its Cobas 6800/8800 Systems and has launched the test in countries that accept the CE marking.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.
This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.
Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.